This article originally appeared in The Hill. Below is an excerpt from the article.
By Nigel Rawson and John Adams, February 3, 2024
After declining similar demands for years, the U.S. Food and Drug Administration (FDA) has, for the first time ever, given permission to import a number of drug classes from Canada for Florida’s Medicare and other recipients.
While Florida seems to think this would save money, pillaging drugs from Canada is a band-aid approach to America’s problem and will cause Canadians much suffering as drug shortages increase north of the border.
One reason that the FDA has denied such demands in the past is a lack of resources necessary to oversee a large-scale importation program and an inability to certify that drugs being imported or trans-shipped were safe and of the same quality as those sold directly into the United States.
Nigel Rawson is a senior fellow with the Center for North American Prosperity and Security.
John Adams is cofounder and CEO of Canadian PKU and Allied Disorders Inc., a senior fellow with the Center for North American Prosperity and Security and volunteer board chair of Best Medicines Coalition.